BMY - Bristol Myers Squibb raises $4.5B through senior unsecured notes offering
2023-10-31 05:37:44 ET
Related stories:
- Bristol-Myers Squibb Company (BMY) Q3 2023 Earnings Call Transcript
- Bristol-Myers Squibb Company 2023 Q3 - Results - Earnings Call Presentation
- Bristol-Myers Squibb Acquisition Of Mirati Makes Sense
- EMA validates Bristol Myers application for Opdivo for urothelial carcinoma
- Karyopharm, Bristol Myers to evaluate drug combination for treatment of multiple myeloma
For further details see:
Bristol Myers Squibb raises $4.5B through senior unsecured notes offering